Abramson Cancer Center at Penn Medicine: all 457 studies

Page 5 of 5. Open to participants first (84), then studies with results posted, then the rest; newest registration first within each.

• Physical Functional Side Effects of Taxane Chemotherapy for Breast CancerCompletedNCT01153282
• Autologous OC-DC Vaccine in Ovarian CancerCompletedNCT01132014Early Phase 1
• Proton Radiotherapy for Recurrent TumorsCompletedNCT01126476Not applicable
• Single Nucleotide Polymorphism (SNP) Panels and Risk Assessment in Women Undergoing MammographyCompletedNCT01124019
• Combination Gene Transfer and ChemotherapyCompletedNCT01119664Phase 1
• Proton Radiation For Meningiomas and HemangiopericytomasCompletedNCT01117844Phase 1/2
• Tremelimumab and CP-870,893 in Patients With Metastatic MelanomaCompletedNCT01103635Phase 1
• Proton Radiation Therapy in Treating Patients With Prostate CancerTerminatedNCT01045226Not applicable
• Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver CancerCompletedNCT01042041Phase 1
• Proton Beam Radiation Therapy in Treating Patients With Retroperitoneal SarcomaWithdrawnNCT01034566Not applicable
• MRI-Guided Radiation Therapy in Treating Patients Who Have Undergone Surgery to Remove the ProstateCompletedNCT01028885Phase 1
• Magnetic Resonance Imaging (MRI) in Predicting Response to Sunitinib Malate in Patients With Locally Advanced or Metastatic Kidney CancerCompletedNCT01026337
• Proton Beam Radiation Therapy in Treating Patients With Low Grade GliomasCompletedNCT01024907Phase 1/2
• A Trial of the Protease Inhibitor Nelfinavir and Concurrent Radiation and Temozolomide in Patients With WHO Grade IV GliomaCompletedNCT01020292Phase 1
• Fluorine F 18 EF5 Positron Emission Tomography in Assessing Hypoxia in Patients With Newly Diagnosed Stage I, Stage II, Stage III, or Stage IV Head or Neck Squamous Cell Cancer of the Oral Cavity, Oropharynx, and LarynxCompletedNCT01020097Not applicable
• Flexitouch Lymphedema System in Treating Stage II Lymphedema in Patients With Breast CancerTerminatedNCT01019512Not applicable
• Proton Beam Radiation Therapy and Cisplatin in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer and Positive Lymph NodesWithdrawnNCT01019278Phase 2
• Cognitive Behavioral Therapy With or Without Armodafinil in Treating Cancer Survivors With Insomnia and Fatigue After ChemotherapyCompletedNCT01019187Phase 2
• Goals of Sexual Function in Prostate Cancer Survivors and Their Partners After Cancer TreatmentCompletedNCT01018901Not applicable
• Magnetic Resonance Imaging in Evaluating Response to RadiationTherapy in Patients With High Grade GliomaCompletedNCT01018329Not applicable
• Positron Emission Tomography in Monitoring Treatment Response in Women With Newly Diagnosed Breast CancerWithdrawnNCT01018251Not applicable
• Visualization of the Effect of Acupuncture on Brain Serotonin in Breast Cancer SurvivorsCompletedNCT01018108Phase 1
• Fluorine F18-EF5 and Fludeoxyglucose F18 Positron Emission Tomography in Assessing Hypoxia and Glycolysis in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung CancerCompletedNCT01017133Phase 1
• Acupuncture in Treating Women With Stage I, Stage II, or Stage III Breast Cancer With Aromatase Inhibitor-Related Joint PainCompletedNCT01013337Not applicable
• Acupuncture and Gabapentin for Hot Flashes Among Breast Cancer SurvivorsCompletedNCT01005108Phase 2
• MRI Mapping in Planning Radiation Therapy to the Base of Skull and Brain in Patients With Nonmetastatic Head and Neck CancerCompletedNCT00984074
• Photodynamic Therapy in Treating Patients With Premalignant or Early Stage Head and Neck TumorsCompletedNCT00978081Phase 1
• Flaxseed Supplement in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Undergoing Chemotherapy and Radiation TherapyTerminatedNCT00955942Phase 1
• Nelfinavir Mesylate, Radiation Therapy, and Temozolomide in Treating Patients With Glioblastoma MultiformeTerminatedNCT00915694Phase 1
• Hydroxychloroquine and Temsirolimus in Treating Patients With Metastatic Solid Tumors That Have Not Responded to TreatmentCompletedNCT00909831Phase 1
• Exercise Programs in Healthy Young Women at Increased Risk of Developing Breast CancerCompletedNCT00892515Not applicable
• Sirolimus in Combination With MEC in High Risk Myeloid LeukemiasCompletedNCT00780104Phase 1
• Infusional C-myb ASODN in Advanced Hematologic MalignanciesCompletedNCT00780052Phase 1
• Rapamycin in With High-Dose Etoposide and Cytarabine in Relapsed/Refractory Aggressive Lymphoid MalignanciesTerminatedNCT00776373Phase 1/2
• Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney CancerStatus unknownNCT00717587Phase 2
• Hydroxychloroquine and Temozolomide in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00714181Phase 1
• A Phase I Clinical Trial of Autologous Dendritic Cell Vaccine for Recurrent Ovarian or Primary Peritoneal CancerCompletedNCT00683241Phase 1
• Bevacizumab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Undergoing Surgery For Locally Advanced Pancreatic CancerCompletedNCT00602602Phase 2
• MRI in Predicting Response in Patients Receiving Combination Chemotherapy and Bevacizumab For Advanced or Metastatic Colorectal CancerTerminatedNCT00602329Phase 2
• Partial Breast Radiation Therapy in Treating Women Undergoing Breast Conservation Therapy for Early-Stage Breast CancerCompletedNCT00599989Not applicable
• Hydroxychloroquine and Bortezomib in Treating Patients With Relapsed or Refractory Multiple MyelomaCompletedNCT00568880Phase 1
• Bevacizumab and Abraxane as Second-line Therapy in Triple Negative Metastatic Breast CancerCompletedNCT00472693Phase 2
• Enhancing Graft vs Leukemia Via Delayed Ex-Vivo Co-Stimulated DLI After Non-Myeloablative Stem Cell TransplantationCompletedNCT00374933Phase 1
• Capecitabine,Oxaliplatin & Erbitux Given Throughout Multi-Modal Therapy for Locally Advanced Rectal AdenocarcinomaTerminatedNCT00353457Phase 2
• Study of Bexarotene in Patients With Acute Myeloid LeukemiaCompletedNCT00316030Phase 1
• Iodine I 131 Monoclonal Antibody TNT-1/B in Treating Patients With Progressive or Recurrent Glioblastoma MultiformeCompletedNCT00128635Phase 1
• Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Ductal Carcinoma In Situ of the BreastCompletedNCT00107211Phase 1
• Vaccine Plus Montanide ISA-51 and Sargramostim in Treating Patients With Stage IV Breast CancerCompletedNCT00079157Phase 1
• Tipifarnib and Radiation Therapy in Treating Patients With Unresectable Locally Advanced Pancreatic CancerCompletedNCT00077519Phase 1
• Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural EffusionsCompletedNCT00066404Phase 1
• Tipifarnib Plus Radiation Therapy After Combination Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung CancerCompletedNCT00025480Phase 1
• Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck CancerTerminatedNCT00003777Phase 2
• MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast CancerCompletedNCT00003736Not applicable
• MRI to Detect Breast Tumors in WomenCompletedNCT00003302Not applicable
• Irinotecan Plus ICI D1694 in Treating Patients With Advanced Solid TumorsCompletedNCT00002902Phase 1
• Gene Therapy in Treating Patients With Primary Brain TumorsCompletedNCT00002824Phase 1
• Chemotherapy and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous LeukemiaCompletedNCT00002592Phase 2

← Abramson Cancer Center at Penn Medicine overview and focus areas